Cloning of diseased cells is now seen as one of the most promising applications of embryonic stem cell research. Dr. Arnold Kriegstein, director of the stem cell institute at the University of California, San Francisco, said he had been approached to be the San Francisco partner of the Korean foundation but had held back, in part because he wished to develop the university's own expertise. "There has been a real chill in the United States with nuclear transfer work because of all the ethical controversies surrounding it," Dr. Kriegstein said. He added that the Koreans had shown the way through their technological advance, and that the technique could probably be improved further if many different laboratories tried to develop it. Scientists in South Korea will help their American colleagues create new lines of embryonic stem cells in an unusual partnership in the contentious field, researchers in both countries announced yesterday. For the Americans, the international consortium, which includes Britain, presents another avenue for working around the Bush administration's refusal to fund most of the research. For the South Koreans, the project brings coveted international recognition of their leadership in the field. "I think this effort points out that science is done on a global scale," said Dr. George Daley, of Children's Hospital in Boston, who hopes to participate in the project. "We can establish restrictions here in the United States, but the science moves forward in other countries." The World Stem Cell Foundation will be led by pioneering stem-cell biologist Hwang Woo-suk at Seoul National University. It will open its first branches in the United States and Britain, Mr. Hwang said in an Associated Press interview before the announcement. (责任编辑:泉水) |